Care Access Research Clifton

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Chronic myeloid leukaemia

Running trials

• Active, not recruiting

  Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

  NCT05384587· Phase 2· Novartis Pharmaceuticals· Source